N. Bejanyan

发表

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations.

A. Jankowska, J. Maciejewski, M. Sekeres, 2010, Leukemia research.

Managing multiple myeloma in a resource-limited region: Diagnosis and treatment in Armenia

N. Bejanyan, D. Kazandjian, A. Oganesyan, 2021, Seminars in Oncology.

Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults.

Christopher G. Kanakry, B. Sandmaier, C. Hourigan, 2021, Transplantation and cellular therapy.

Impact of total body irradiation based myeloablative conditioning regimen in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant: systematic review and meta-analysis.

J. Pidala, A. Mishra, L. Ochoa, 2021, Transplantation and cellular therapy.

A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF)

A. Jankowska, J. Maciejewski, Y. Saunthararajah, 2012, Cancer.

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndromes Patients ≥70 Years Old

M. Arora, N. Bejanyan, T. DeFor, 2016 .

Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.

D. Weisdorf, M. Arora, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The revolution of myelodysplastic syndromes

M. Sekeres, N. Bejanyan, 2011, Therapeutic advances in hematology.

Matching at HLA-C improved the outcomes after double umbilical cord blood transplantation for recipients of 2–4/6 HLA-matched grafts

J. Wagner, K. Ballen, R. Soiffer, 2017 .

Lower GVHD and relapse risk in PTCy-based Haploidentical vs Matched Sibling Donor RIC Transplant for Hodgkin Lymphoma

M. Aljurf, J. Bolaños-Meade, Y. Nieto, 2019 .

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

Alan M. Miller, M. Norkin, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative Donor Transplantation for Acute Myeloid Leukemia

N. Bejanyan, C. Brunstein, H. Haddad, 2015, Journal of clinical medicine.

Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation

J. Wagner, G. Vercellotti, M. Verneris, 2014, Bone Marrow Transplantation.

TP53 Mutations in Myeloid Malignancies are either Homozygous or Hemizygous due to Copy Number-Neutral Loss of Heterozygosity or Deletion of 17p

M. McDevitt, L. Gondek, J. Maciejewski, 2009, Leukemia.

First-line hypomethylating agents for patients with high risk chronic myelomonocytic leukaemia.

C. Anasetti, N. Bejanyan, 2021, The Lancet. Haematology.

Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.

J. Wagner, M. Linden, M. Verneris, 2021, Transplantation and Cellular Therapy.

Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation.

Tallman, B. Sandmaier, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic factors for clinical outcomes of patients with central nervous system leukemia

D. Weisdorf, V. Bachanova, N. Bejanyan, 2020, Hematology/oncology and stem cell therapy.

Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation

A. Mishra, J. Lancet, E. Padron, 2019, Blood.

Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.

M. Wlodarski, J. Maciejewski, R. Paquette, 2011, Blood.

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

E. Estey, B. Sandmaier, M. Krem, 2021, Bone Marrow Transplantation.

T/NK large granular lymphocyte leukemia and coexisting monoclonal B-cell lymphocytosis-like proliferations. An unrecognized and frequent association.

J. Maciejewski, E. Hsi, N. Bejanyan, 2010, American journal of clinical pathology.

Absence of early HHV‐6 reactivation after cord blood allograft predicts powerful graft‐versus‐tumor effect

Jeffrey S. Miller, D. Weisdorf, A. Rashidi, 2018, American journal of hematology.

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

C. Craddock, V. Brown, C. Hourigan, 2022, Leukemia.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

B. Sandmaier, M. Horowitz, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines.

M. Robin, G. Garcia-Manero, Z. DeFilipp, 2022, Transplantation and cellular therapy.

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2019, Blood advances.

Second allogeneic hematopoietic cell transplantation for graft failure: Poor outcomes for neutropenic graft failure

J. Wagner, J. Tolar, D. Weisdorf, 2015, American journal of hematology.

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

J. Pidala, A. Mishra, Jongphil Kim, 2021, Blood advances.

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Christelle M Colin-Leitzinger, B. Sahaf, A. Mishra, 2022, Blood advances.

ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

J. Pidala, A. Mishra, J. Lancet, 2021, Transplantation and cellular therapy.

Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).

L. Rybicki, M. Kalaycio, B. Pohlman, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2018, Blood advances.

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells

A. Landin, Justin C. Boucher, C. Anasetti, 2020, Journal of immunotherapy.

Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor type.

M. Robin, D. Weisdorf, G. Socié, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index.

D. Weisdorf, M. Arora, A. Rashidi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

R. Vij, B. Sandmaier, M. Aljurf, 2019, Haematologica.

Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study.

S. Devine, D. Weisdorf, B. Logan, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia

M. Wlodarski, J. Maciejewski, N. Bejanyan, 2009, Haematologica.

Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical HCT with Post-Transplant Cyclophosphamide

G. Marcucci, J. Pidala, S. Forman, 2021, Transplantation and Cellular Therapy.

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2015, Blood.

Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide

J. Pidala, A. Mishra, Jongphil Kim, 2021, Bone Marrow Transplantation.

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation

N. Bejanyan, H. Elmariah, C. Brunstein, 2021, Life.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

B. Sandmaier, M. Aljurf, R. Gale, 2019, Blood advances.

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2018, Haematologica.

Treatment of relapsed/refractory acute myeloid leukaemia in adults

D. Weisdorf, A. Rashidi, N. Bejanyan, 2018, British journal of haematology.

Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts.

J. Wagner, K. Ballen, R. Soiffer, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation.

A. Ganser, M. Labopin, A. Nagler, 2020, Blood advances.

Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased infections and delayed CD4+ T-cell but faster B-cell Immune Reconstitution after Posttransplant Cyclophosphamide Compared to Conventional GVHD prophylaxis in Allogeneic Transplantation.

J. Pidala, Junmin Whiting, A. Mishra, 2021, Transplantation and cellular therapy.

Survival of AML patients relapsing after allogeneic hematopoietic cell transplantation: a CIBMTR study

S. Devine, D. Weisdorf, B. Logan, 2015 .

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

A. Gennery, M. Aljurf, B. George, 2019, Blood advances.

Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

M. Linden, D. Weisdorf, N. Bejanyan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation.

J. Wagner, J. Miller, I. Vlasova-St Louis, 2021, Transplantation and cellular therapy.

BMT CTN 1803: Trial to Investigate If Haploidentical Natural Killer Cells (CSTD002) Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

S. Devine, E. Krakow, B. Logan, 2020 .

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

M. Linden, A. Rashidi, J. Miller, 2018, Bone Marrow Transplantation.

Immune Reconstitution after Umbilical Cord Blood Versus Peripheral Blood Progenitor Cell Transplantation in Adults Following Myeloablative Conditioning

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2016 .

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

J. Wagner, D. Weisdorf, M. Verneris, 2016, Haematologica.

Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results

S. Sebti, J. Pidala, A. Mishra, 2021, Clinical Cancer Research.

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.

Sonali M. Smith, Z. DeFilipp, H. Lazarus, 2018, Blood advances.

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

K. Dusenbery, G. Vercellotti, Jeffrey S. Miller, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation

M. Aljurf, R. Gale, L. Lekakis, 2020, Cancer.

History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease‐negative first complete remission

M. Linden, D. Weisdorf, A. Rashidi, 2017, American journal of hematology.

Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-Versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation.

M. Kidd, J. Pidala, A. Mishra, 2022, Transplantation and cellular therapy.

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation.

J. Pidala, A. Mishra, Xuefeng Wang, 2021, Blood advances.

Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.

M. Pasquini, J. Wingard, K. Ballen, 2019, Blood advances.

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

F. Baron, M. Krem, C. Hourigan, 2021, Bone Marrow Transplantation.

Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

M. Reding, D. Weisdorf, M. Reding, 2015, Bone Marrow Transplantation.

Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced intensity conditioning umbilical cord blood transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.

M. Perales, M. Aljurf, Y. Nieto, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weight‐based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2018 .

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

M. Robin, M. MacMillan, D. Weisdorf, 2016, Haematologica.

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.

M. Krem, Stephanie J. Lee, K. Syrjala, 2021, Transplantation and cellular therapy.

Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human Product.

A. Landin, N. Bejanyan, Bin Yu, 2021, Journal of visualized experiments : JoVE.

Is It All About Age or Personalized Haploidentical Hematopoietic Stem Cell Transplantation for Elderly Patients?

N. Bejanyan, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of type of reduced‐intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma

N. Ghosh, M. Cairo, U. Farooq, 2020, British journal of haematology.

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

M. Pasquini, J. Wingard, K. Ballen, 2018, Blood.

A real-world study of clofarabine and cytarabine combination therapy for patients with acute myeloid leukemia

D. Weisdorf, A. Rashidi, N. Bejanyan, 2018, Leukemia & lymphoma.

CD34+ Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

J. Pidala, A. Mishra, Jongphil Kim, 2019, Blood.

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

N. Bejanyan, C. Ustun, C. Brunstein, 2016, Bone Marrow Transplantation.

Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients

D. Weisdorf, M. Arora, V. Bachanova, 2014, American journal of hematology.

A gut-graft axis mediated by microbiota.

A. Rashidi, N. Bejanyan, 2022, Blood.

Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia

J. Maciejewski, A. Advani, M. Sekeres, 2010, Cancer.

A Phase 1/1b Safety Study of Prgn-3006 Ultracar-T™ in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome

A. Mishra, J. Lancet, H. Sabzevari, 2020, Blood.

Multicenter Pilot Clinical Trial of Enasidenib As Maintenance Therapy after Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia (AML) Carrying IDH2 Mutations

G. Marcucci, I. Aldoss, S. Forman, 2022, Blood.

A. Jankowska, J. Maciejewski, Y. Saunthararajah, 2012, Cancer.

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

J. Pidala, A. Mishra, Jongphil Kim, 2022 .

Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemia

J. Medin, H. Spencer, C. Doering, 2023, Frontiers in immunology.

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.

Sonali M. Smith, J. Bolaños-Meade, Z. DeFilipp, 2018, Blood advances.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

B. Sandmaier, M. Aljurf, R. Gale, 2019, Blood advances.

B. Sandmaier, M. Aljurf, M. Grunwald, 2019, Haematologica.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.